AI assistant
Elementis PLC Director's Dealing 2022
4640_mang_2022-03-01_785bc67b-d6cd-4985-ac92-a85ee2898e01.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 2349D
Elementis PLC
01 March 2022
1 March 2022
Elementis plc (the "Company") - Director declaration
In accordance with Listing Rule 9.6.14, the Company today confirms that Anne Hyland, one of its non-executive directors, has been appointed as a non-executive director of Mereo BioPharma Group Plc, a biopharmaceutical company developing and commercialising new therapies for oncology and rare diseases, which is listed on the NASDAQ exchange under MREO ticker.
Laura Higgins
Group Company Secretary
020 7067 2999
LEI: 549300LQIH685LI2ML36
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RDNSSFFLFEESESD